American Association for Cancer Research

Program

Program as of October 24, 2008

MONDAY, OCTOBER 27

REGISTRATION

8:00 a.m.-7:00 p.m.
Research Studies Center, outside of the Hohn Lecture Hall

EDUCATIONAL SESSIONS

10:00 a.m.-12:00 p.m.

  • IMPACT OF TRANSLATIONAL RESEARCH ON THE CLINIC – MOLECULAR TARGETED THERAPY AND PATIENT OUTCOME
    Chairperson: Clara D. Bloomfield, Ohio State University Comprehensive Cancer Center, Columbus, OH


    Clinical Use of Molecular Markers in Curing Acute Myeloid Leukemia
    Clara D. Bloomfield

    Integration of Molecular Mechanisms of Drug Action into Clinical Treatment Decisions
    Gerold Bepler, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

    Title to be announced
    Ravindra Pandey, Roswell Park Cancer Institute, Buffalo, NY

  • APPLICATION OF INNOVATIVE TECHNOLOGIES OF THE 21ST CENTURY – AN OVERVIEW
    Chairperson: Norma J. Nowak, Roswell Park Cancer Institute, Buffalo, NY


    Dynamic Molecular Imaging of Signal Transduction Pathways in Discovery Research
    David Piwnica-Worms, Washington University School of Medicine, St. Louis, MO

    Biomedical Informatics: Enabling Cancer Researchers to see the Forest AND the Trees
    Kenneth H. Buetow, National Cancer Institute, Bethesda, MD

    Sequencing the Cancer Genome
    Richard K. Wilson, Washington University School of Medicine, St. Louis, MO

OPENING LUNCHEON / KEYNOTE TALK

Chairpersons: Raymond N. DuBois, UT M. D. Anderson Cancer Center, Houston, TX and Donald L. Trump, Roswell Park Cancer Institute, Buffalo, NY
12:00 p.m.–1:30 p.m.

Transforming FDA Science: Implications for Cancer Research
Frank M. Torti, Food and Drug Administration, Rockville, MD

PLENARY SESSION 1
EXPERIMENTAL AND MOLECULAR THERAPEUTIC ADVANCES – WHAT THE FUTURE HOLDS

Chairperson: Candace S. Johnson, Roswell Park Cancer Institute, Buffalo, NY
1:45 p.m.–3:45 p.m.

Epigenetic Silencing of Endothelial Cells in the Tumor Microenvironment
Candace S. Johnson

Normalizing Tumor Microenvironment to Treat Cancer: From Bench to Bedside and Back
Rakesh K. Jain, Massachusetts General Hospital, Boston, MA

Epigenetic Contributions to Chronic Lymphocytic Leukemia
Christoph Plass, German Cancer Research Center, Heidelberg, Germany

The HIF/VHL Pathway as a Paradigm for the Targeting of the Tumor Microenvironment Therapeutically
Amato J. Giaccia, Stanford University School of Medicine, Stanford, CA

PLENARY SESSION 2
THE EMERGING FIELDS OF PROTEOMICS AND SYSTEMS BIOLOGY

Chairperson: Kenneth H. Buetow, National Cancer Institute, Bethesda, MD
4:00 p.m.–6:00 p.m.

Systems Biology and Systems Medicine
Leroy E. Hood, The Institute for Systems Biology, Seattle, WA

Fast Tracking the Development of Cancer Biomarkers Using Proteomics
Samir M. Hanash, Fred Hutchinson Cancer Research Center, Seattle, WA

Linking Measurement and Mathematics in a Quantitative Analysis of Anti-Cancer Therapy
Peter Sorger, Harvard Medical School, Boston, MA

OPENING DINNER / KEYNOTE TALK

7:00 p.m.–9:00 p.m.

Future Trends in Cancer Research
Donald S. Coffey, Johns Hopkins University School of Medicine, Baltimore, MD

 

TUESDAY, OCTOBER 28

PLENARY SESSION 3
THE KNOWLEDGE WITHIN GENOMICS AND CANCER GENOMICS RESEARCH

Chairperson: Nickolas Papadopoulos, Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins Institutes' Ludwig Center for Cancer Genetics and Therapeutics, Baltimore, MD
8:30 a.m.–10:15 a.m.

The Genetic Landscape of Cancer
Nickolas Papadopoulos

Non-coding RNA: Principle in Medical Practice
George A. Calin, UT M. D. Anderson Cancer Center, Houston, TX

Title to be announced
Moray J. Campbell, Roswell Park Cancer Institute, Buffalo, NY

PLENARY SESSION 4
THE RELEVANCE AND CHALLENGES OF CANCER PREVENTION RESEARCH WITH A FOCUS ON MOLECULAR EPIDEMIOLOGY

Chairperson: Christine B. Ambrosone, Roswell Park Cancer Institute, Buffalo, NY
10:30 a.m.–12:00 p.m.

Molecular Epidemiology in Cancer Prevention and Control
Christine B. Ambrosone

Molecular Targeting and the Prevention-Therapy Convergence
Scott M. Lippman, UT M. D. Anderson Cancer Center, Houston, TX

Molecular Epidemiology: Looking Towards the Future
Nathaniel Rothman, National Cancer Institute, Bethesda, MD

CLOSING LUNCHEON / KEYNOTE TALK

Chairperson: Raymond N. DuBois, UT M. D. Anderson Cancer Center, Houston, TX
12:15 p.m.–1:45 p.m.

The Future of Cancer Research
Harold L. Moses, Vanderbilt-Ingram Cancer Center, Nashville, TN

CLOSING REMARKS

1:45 p.m.–2:00 p.m.

Raymond N. DuBois, UT M. D. Anderson Cancer Center, Houston, TX and Donald L. Trump, Roswell Park Cancer Institute, Buffalo, NY

DEPARTURE